'
Privi Speciality Chemicals hosted a conference call on February 10, 2026.
In the conference call the company was represented by Mr Mahesh Babani- CMD, Mr
Rajan –President, Mr Sanjeev Patil VP-Strategy and Biotechnology and Mr Narayan
Iyer -CFO.
Key takeaways of the call
Despite the challenging global environment marked by tariff-related
geopolitical uncertainties impacting global trade, the company has continued to
demonstrate resilient and robust performance during this period. The
performance is driven by our diversified product mix, focused on operational
excellence and disciplined execution of projects.
The company has delivered upward of 20% EBITDA margin for the last 10
quarters and the company has delivered 255 EBITDA margin for the last 3
quarters. The company has maintained profit margins by improving process
yields, reducing operating costs and deriving benefits of economies of scale.
On a QoQ basis r...
Pleaselogin & subscribe to view the full report.
More Reports
|
|